CD
Chen Daniel ShinYu
Directeur Médical
OtherM
Insider track record
ExecutiveNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Chen Daniel ShinYu, Directeur Médical. Officer active across 1 company, notably IGM Biosciences, Inc.. Aggregated, 12 filings have been published. Split: 0 buy · 4 sells. Total volume traded: €100k. Activity tracked since 3 May 2021. The latest transaction was filed on 1 July 2021 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations12 total
1,900 shares@ US$1.392.0% of flowCommon StockSEC:0001209191-21-045686:0
1,900 shares@ US$1.392.0% of flowCommon StockSEC:0001209191-21-045686
1,900 shares@ US$1.391.9% of flowCommon StockSEC:0001209191-21-038001:0
1,900 shares@ US$1.391.9% of flowCommon StockSEC:0001209191-21-038001
444 shares@ US$70.0022.6% of flowCommon StockSEC:0001209191-21-036646:0
444 shares@ US$70.0022.6% of flowCommon StockSEC:0001209191-21-036646
900 shares@ US$1.390.9% of flowCommon StockSEC:0001209191-21-033858:0
900 shares@ US$1.390.9% of flowCommon StockSEC:0001209191-21-033858
469 shares@ US$62.315621.6% of flowCommon StockSEC:0001209191-21-030751:0
469 shares@ US$62.315621.6% of flowCommon StockSEC:0001209191-21-030751
950 shares@ US$1.391.0% of flowCommon StockSEC:0001209191-21-030526
950 shares@ US$1.391.0% of flowCommon StockSEC:0001209191-21-030526:0
About Chen Daniel ShinYu
Daniel ShinYu Chen is the Chief Medical Officer at IGM Biosciences, Inc. He oversees the company's clinical initiatives and medical strategies. His expertise in medicine and research is essential for developing new therapeutic solutions.